** Pfizer's PFE.N shares rise 1.7% to $23.44 premarket
** PFE posts Q1 adj EPS of $0.92, beating analysts' estimates of $0.67, per data compiled by LSEG
** While Q1 revenue misses estimates, but still sticks by FY revenue forecast of $61-$64 billion
** Also maintains FY adj EPS outlook of $2.80-$3.00
** As of last close, PFE has fallen about 13% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.